Chocolate Cannabis Grahams Make Your Day Bear-able
Category: Medical Marijuana | Posted on Tue, December, 20th 2011 by THCFinder
The bare truth is, some days you eat the bear, and some days the bear eats you. If you're shooting for the former state of affairs, you can definitely do worse than to stop by Locals Social Club in Shoreline (with, of course, a medical marijuana authorization) to try their Chocolate Bear Grahams, which definitely bear up under scrutiny.
Bear in mind that these delicious treats -- a true Deadhead-friendly medication delivery system -- will, about an hour after ingestion, have a much more than barely noticeable effect not only upon your body pain (as in greatly lessening it) and appetite (as in, in a fairly short time, greatly increasing it), but also upon your mental state (as in noticeably altering it).
At the bare minimum expenditure of just $5, a little snack tray full of these bears -- which aren't so sweet and filling as many other medibles -- can make your pain and stress level bearable. Besides that, the little bite-sized bears are quite satisfying and fun to munch, and that's the bare truth.
That noticeably oily sheen the bears have is due to their medicated nature; cannabinoids including THC need a carrying agent with some fat to assist their assimilation in your digestive tract.
My recommendation is that you go ahead and finish the entire container of bears at once, unless you are particularly sensitive to the effects of cannabis, in which case you should perhaps try half a container and wait an hour to gauge the effects before consuming more.
You can get your Chocolate Graham Bears, along with a wide selection of other medicated edibles, at Locals Social Club, 938 N. 200th St, Suite B (upstairs) in Shoreline, telephone 629-4985. They're open from 10 a.m. until midnight Sunday through Thursday, and from 10 a.m. until 3 a.m. Friday and Saturday.
Written by: Steve Elliott
Help Stop Government from Issuing Exclusive License for Medical Cannabis
Category: Medical Marijuana | Posted on Mon, December, 19th 2011 by THCFinder
As you well know, our federal government maintains that marijuana has “no currently accepted medical use” as a schedule I substance per the Controlled Substance Act. Although sixteen states and the District of Columbia have now passed medical marijuana legislation, the Department of Justice (DOJ) continues to enforce federal law and prosecute those who cultivate, distribute, or possess medical marijuana in compliance with state law.
While the DOJ intimidates and incarcerates medical marijuana patients based upon federal position that cannabis has no medical value, another cabinet-level department within the federal executive branch, the Department of Health and Human Services (HHS), holds the legal right to certain medical applications of cannabinoids; since October 2003, the United States of America, as represented by the Department of Health and Human Services, has been official assignee of U.S. Patent #6630507, entitled “Cannabinoids as antioxidants and neuroprotectants. ” The Union of Medical Marijuana Patients (UMMP) has been well aware of this outrageous hypocrisy for several years now.
However, recent developments beg immediate attention and action from the broader community of medical marijuana advocates, as well as from all Americans who disagree with government-driven financial exploitation and monopolization of the very plant for which hundreds of thousands of American citizens are currently incarcerated.
The notion that one federal bureaucracy claims ownership rights to medical marijuana while its sister department prosecutes the patients who depend upon this government patented “invention” is outrageous enough. However, the Union of Medical Marijuana Patients discovered this week that the federal government now intends to grant an exclusive license to “practice the invention embodied in U.S. Patent 6,630,507” to a single New York based pharmaceutical corporation. In accordance with regulations that dictate how exclusive licenses may be granted on Government owned inventions, 37 CFR part 404.7 (a)(1) (i), the HHS published notice of its intentions in the November 17th edition of the Federal Register.
With a posting entitled “Prospective Grant of Exclusive License: Development of Cannabinoid(s) and Cannabidiol(s) Based Therapeutics to Treat Hepactic Encephalopathy in Humans,” the Department of Health and Human Services announced its plan to grant KannaLife Sciences, Inc. an exclusive license to “development and sale of cannabinoid(s) and cannabidiol(s) based therapeutics as antioxidants and neuroprotectants for use and delivery in humans. ”
Local cannabis company announces success with cancer treatment
Category: Medical Marijuana | Posted on Thu, December, 15th 2011 by THCFinder
Denver-based Cannabis Science, Inc. announced this week that a cancer patient has had success using the company’s cannabis-based product in the treatment of skin cancer.
The biotech company, which develops pharmaceutical cannabis products, said this is the second patient to use the product successfully. “This patient has photo-documented dramatic results that we will release to the public once treatment is completed and has been properly vetted by clinical biopsy,” the company said in a press release. “Cannabis Science, in conjunction with several Colorado-licensed dispensaries and physicians, consults with a number of cancer patients who were seeking to inform themselves of the current peer-reviewed scientific literature, regarding modern and historical use of cannabis preparations for treating cancers so that they can make informed decisions regarding their self-directed cancer treatment.”
More from the press release:
Cannabis has an outstanding safety profile as determined in 1988 by Federal Administrative Law Judge Francis Young who recommended cannabis be removed from Schedule I. The refusal of the DEA to follow this recommendation has resulted in 16 states allowing some form of medical marijuana access for their citizens. Numerous other states are moving in this direction. Consequently, patients in states with medical marijuana laws are able to make an informed decisions to try various state-legal cannabis preparations and to determine what is most effective for their particular condition. As a result, there is an unprecedented accumulation of “anecdotal” data
Currently, there are a variety treatments available for treating various skin cancers including standard surgical excision (Mohs Surgery), chemotherapy, radiation, and cryosurgery. Unfortunately for many, the cancer frequently returns and requires additional treatments. Chemo and radiation therapy are typically used by patients who aren’t candidates for surgery (i.e. where surgical excision could disfigure or make it difficult to reconstruct the excised area). If reoccurrence occurs, radiation therapy is often not repeated as it may further damage the tissue (and) lead to resistance.
While the above treatments may to be effective for many, few patients would choose to go through surgical procedures, radiation, or chemotherapy if a better alternative were available. Patients self-administering cannabis extracts in the convenience of their own home appear to be effectively resolving their cancerous lesions over a period of a few weeks to a few months.
Cannabis Science is committed to making cannabis-based medicines available to the public as rapidly as possible. The Company is taking multiple approaches to accomplishing this aim in the United States. The science of cannabinoids has exploded over the past decade, laying the scientific foundation for the many medicinal uses of this unique plant. Cannabinoids are a class of biologically active compounds produced by all vertebrates (endocannabinoids) the Cannabis plant (phytocannabinoids), and more recently patentable synthetic compounds produced by chemists. Today’s modern peer-reviewed science supports the many historical uses that were discovered over thousands of years of medicinal use by herbalists.
Thousands of Colo. marijuana applications on hold
Category: Medical Marijuana | Posted on Mon, December, 12th 2011 by THCFinder
DENVER | Some 4,200 medical marijuana applications in Colorado are on hold at the state health department while investigators look at possible fraud.
The Colorado Department of Public Health and Environment announced Friday that marijuana registry applications from certain physicians are on hold after law enforcement officials witnessed potential patients being seen by someone other than a physician. Colorado law requires a "bona fide" doctor-patient relationship before a physician can recommend marijuana pot for certain ailments.
The health department did not say which doctors were under investigation, or how law enforcement came to find out about the possible fraud. The agency said only that certain physicians would be contacted to confirm they examined would-be patients and signed their recommendations.
State lawmakers tightened physician requirements for medical marijuana cards in 2010 after concerns about possible fraud. Colorado now requires that a physician perform a personal physical examination of a would-be patient, keep records of the visit and offer follow-up care.
The health department said Friday that the applicants on hold will receive an answer by the end of January.
The head of the department, Dr. Chris Urbina, acknowledged in a statement Friday that some patients have seen lengthy delays. But he said the review is necessary to make sure all the pending recommendations meet medical muster.
"The investigation was necessary to maintain the integrity of the Medical Marijuana Registry," Urbina's statement said.
Urbina went on, "The exposure of this fraud should lead marijuana registry applicants to take care to ensure that they are seen and examined by a physician if they intend to apply to the medical marijuana registry."
VIDEO: Polis questions AG Holder on Medical Marijuana
Category: Medical Marijuana | Posted on Mon, December, 12th 2011 by THCFinder
Eric Holder okay with lawful MMCs, but do threats remain?
Category: Medical Marijuana | Posted on Fri, December, 9th 2011 by THCFinder
This week, Congressman Jared Polis quizzed U.S. Attorney General Eric Holder about the Department of Justice's approach to medical marijuana; see a video of the exchange below. For the most part, Holder suggested that MMJ businesses following state law are not Department of Justice priorities, despite recent crackdowns in California and elsewhere. Attorney Jessica Peck sees positives in his responses, but also areas of concern for the industry.
Peck, a lawyer and political strategist for Henley Public Affairs, is a fan of Polis's. "I've spoken with him, and I'm very impressed with how he talks with all the different stakeholders and works with everyone, including Republicans," she says. "I think he went into the committee hearing trying to get points from all perspectives, which is what a congressman should do."
Regarding Holder's responses to Polis's questions, she calls them "fascinating, because you have the White House now saying it stands behind its previous position as outlined in the Ogden memo" -- a 2009 document penned by Deputy Attorney General David Ogden, which directed U.S. Attorneys not to target medical marijuana businesses in states where they're legal as long as they're following state law.
This summer, a memo by another deputy attorney general, James Cole "articulated a different position" than did the Ogden directive, Peck believes. In it, Cole wrote that while "it is likely not an efficient use of federal resources to focus enforcement efforts on individuals with cancer or other serious illnesses who use marijuana as part of a recommended treatment regiment consistent with applicable state law, or their caregivers," he stressed that the term "caregiver" means "individuals providing care to individuals with cancer or other serious illnesses, not commercial operations cultivating, selling or distributing marijuana." In other words, a dispensary isn't a caregiver.
Given this apparent shift, Peck was cheered when Holder said the Ogden memo is still current. That shows "the White House is standing behind its original position," she feels, "and that's significant. And I also thought Holder's wording was interesting. It was clear he didn't know a lot about Colorado's system. But he did say it's the federal government's position that so long as people are acting in conformity with state law, the feds don't see it as a law enforcement priority. That's different from what was previously said, which called for 'unambiguous compliance.'
- 193,972 Views Category: Odd
- 152,899 Views Category: Fun
- 142,417 Views Category: Culture
- 105,183 Views Category: Culture
- 103,544 Views Category: Culture
- 102,364 Views Category: Fun
- 82,727 Views Category: Culture
- 80,986 Views Category: Odd
- 72,906 Views Category: Fun
- 66,277 Views Category: Fun